SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Clin Gastroenterol Hepatol. 2018;16(1):123-131.e1.

Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.

, , , , ,

제1저자 김원, 김동희 · 교신저자 김원, 김동희

소속 (5)
  1. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. Electronic address: messmd@chol.com.
  2. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea. Electronic address: drwon1@snu.ac.kr.
  3. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  4. Department of Pathology, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.
  5. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.

Abstract

BACKGROUND & AIMS Variations in level of thyroid-stimulating hormone (TSH) within the reference range of thyroid hormone could have negative health effects. We evaluated the effect of plasma TSH levels within the euthyroid range on the severity of histological damage associated with nonalcoholic fatty liver disease (NAFLD).

METHODS We performed a cross-sectional study of 425 subjects with biopsy-proven NAFLD (mean age, 53 years; 52% male) who participated in the Boramae NAFLD study from January 2013 to January 2017. Each subject underwent an anthropometric assessment and laboratory and clinical evaluations. Of the subjects, 282 were assigned to a strict-normal thyroid function group (plasma level of TSH, 0.4 to 2.5 mIU/L). Patients with low thyroid function were assigned to groups of subclinical hypothyroidism (plasma level of TSH above 4.5 mIU/L with a normal thyroid hormone level; n = 59) or low-normal thyroid function (higher plasma TSH level [2.5 to 4.5 mIU/L] with a normal thyroid hormone level; n = 84). Multivariate logistic regression analysis was used to identify factors independently associated with nonalcoholic steatohepatitis (NASH) and advanced fibrosis.

RESULTS NASH and advanced fibrosis were found in higher percentages of subjects with low thyroid function vs strict-normal thyroid function (52.4% vs 37.2% for NASH and 21.0% vs 10.6% for advanced fibrosis; P < .01). Among subjects with low thyroid function, a higher proportion of patients with subclinical hypothyroidism had NASH and associated advanced fibrosis vs patients with low-normal thyroid function (57.6% vs 48.8% for NASH and 25.4% vs 17.9% for advanced fibrosis; P < .01). Subjects with low thyroid function had more extensive hepatic steatosis with greater severity of balloon degeneration and fibrosis. In multivariate analyses, low thyroid function was significantly associated with NASH (odds ratio, 1.61; 95% CI, 1.04-2.50; P = .035) and advanced fibrosis (odds ratio, 2.23; 95% CI, 1.18-4.23; P = .014). Risks of NASH and advanced fibrosis increased significantly with plasma concentration of TSH (Ptrend <.05 for each).

CONCLUSIONS Subclinical hypothyroidism and low-normal thyroid function are independent predictors of NASH and advanced fibrosis, confirming the relationship between these diseases. ClinicalTrials.gov, Number: NCT02206841.

Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Keywords

Hepatic SteatosisThyroid DysfunctionThyroxine

그 밖의 정보
출판 형태
Journal Article
저널
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · eISSN 1542-7714
전자 출판
2017-08-18
MeSH
Adolescent · Adult · Aged · Aged, 80 and over · Asymptomatic Diseases / epidemiology · Cross-Sectional Studies · Female · Humans · Hypothyroidism / epidemiology / etiology · Liver Cirrhosis / complications · Male · Middle Aged · Non-alcoholic Fatty Liver Disease / complications · Thyrotropin / blood · Young Adult
Substances
Thyrotropin
데이터
ClinicalTrials.gov: NCT02206841